PROM1 and neoplasm: used gene knockout technology to knock down the CD133 gene of tumor stem cells, and the tumor growth was not inhibited, indicating that TRAIL can be used as a therapeutic drug for CD133 (+) tumor stem cells Figure 5D (68).